INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share (IAS)

CUSIP: 45828L108

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
167,832,380
Total 13F shares
151,179,932
Share change
-190,492
Total reported value
$1,507,267,904
Put/Call ratio
114%
Price per share
$9.97
Number of holders
164
Value change
-$34,001,193
Number of buys
100
Number of sells
87

Security key

45828L108

Report period

Q1 2024

Institutions

164

Top holders

10

Ownership snapshot

Top shareholders of IAS - INTEGRAL AD SCIENCE HOLDING CORP. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
164
Shares
151,179,932
Rows loaded
165
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
173
Q1 2024 holders
164
Holder diff
-9
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .